Get the Stockscreener App
10.11
0.35%
-0.035
Drugs Made In America Acquisition Corp stock is traded at $10.11, with a volume of 1,023.
It is down -0.35% in the last 24 hours and up +0.34% over the past month.
Drugs Made In America Acquisition Corp is a blank check company.
See More
Previous Close:
$10.14
Open:
$10.12
24h Volume:
1,023
Relative Volume:
0.00
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-0.25%
1M Performance:
+0.34%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$10.10
$10.12
1-Week Range:
$10.08
$10.20
52-Week Range:
$10.00
$10.82
Drugs Made In America Acquisition Corp Stock (DMAAU) Company Profile
Name
Drugs Made In America Acquisition Corp
Sector
Industry
Phone
-
Address
-
Compare DMAAU with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DMAAU
Drugs Made In America Acquisition Corp
|
10.11 | 0 | 0 | 0 | 0 | 0.00 |
|
LION
Lionsgate Studios Corp
|
7.56 | 2.18B | 3.13B | 50.80M | 555.00M | 0.1772 |
|
AACT
Ares Acquisition Corporation Ii
|
11.16 | 697.50M | 0 | 16.92M | -1.35M | 0.29 |
|
ANSC
Agriculture Natural Solutions Acquisition Corp
|
10.62 | 457.99M | 0 | 1.30M | 0 | 0.0301 |
|
AAM
Aa Mission Acquisition Corp
|
10.22 | 449.41M | 0 | 0 | 0 | 0.00 |
|
EQV
Eqv Ventures Acquisition Corp
|
10.05 | 447.95M | 0 | 0 | 0 | 0.00 |
Drugs Made In America Acquisition Corp Stock (DMAAU) Latest News
7 Best Weight Loss Drug Stocks to Buy in 2025 | Investing | U.S. News - U.S News & World Report Money
Layoff Tracker: Atea Pharmaceuticals Cuts 25% of Workforce - BioSpace
Q1 Earnings Estimate for WSP Global Issued By Raymond James - Defense World
Brokerages Set TWFG, Inc. (NASDAQ:TWFG) Target Price at $31.86 - Defense World
adidas AG (OTCMKTS:ADDYY) Sees Large Growth in Short Interest - Defense World
ACS, Actividades de Construcción y Servicios, S.A. (OTCMKTS:ACSAY) Short Interest Up 104.9% in February - Defense World
Acorn Energy, Inc. (OTCMKTS:ACFN) Sees Large Increase in Short Interest - Defense World
Smithfield Foods, Inc’s (NASDAQ:SFD) Quiet Period Set To Expire on March 10th - Defense World
Short Interest in ANA Holdings Inc. (OTCMKTS:ALNPY) Decreases By 33.3% - Defense World
Alfa S.A.B. de C.V. (OTCMKTS:ALFFF) Short Interest Up 79.6% in February - Defense World
AIA Group Limited (OTCMKTS:AAGIY) Short Interest Update - Defense World
Aker ASA (OTCMKTS:AKAAF) Short Interest Up 61.0% in February - Defense World
Athena Gold Co. (OTCMKTS:AHNR) Sees Significant Growth in Short Interest - Defense World
Short Interest in Agricultural Bank of China Limited (OTCMKTS:ACGBF) Increases By 74.0% - Defense World
Short Interest in Alaris Equity Partners Income Trust (OTCMKTS:ADLRF) Grows By 137.9% - Defense World
AddLife AB (publ) (OTCMKTS:ADDLF) Short Interest Update - Defense World
Financial Comparison: Thomasville Bancshares (OTCMKTS:THVB) & U.S. Bancorp (NYSE:USB) - Defense World
OSI Systems (NASDAQ:OSIS) vs. Applied Optoelectronics (NASDAQ:AAOI) Critical Contrast - Defense World
Endava plc (NYSE:DAVA) Receives $39.10 Consensus Target Price from Brokerages - Defense World
Sanctuary Advisors LLC Has $782,000 Stake in Vornado Realty Trust (NYSE:VNO) - Defense World
Drugs Made in America Acquisition Corp. Announces Advisory Team - The Manila Times
CanadaHelps Estimates $266 Million Loss for Charities Due to Canada Post Strike; Urges Canadians to Use Extended Donation Deadline to Give - The Manila Times
Drugs Made in America Acquisition Corp. Forms Advisory Team to Pursue Pharmaceutical Business Acquisitions - Nasdaq
Can This Power Team of Healthcare Veterans Reshape American Drug Manufacturing? - StockTitan
Popular cannabis brand declares Chapter 11 bankruptcy - TheStreet
Drugs Made In America Acquisition Corp. Announces the Separate Trading of its Ordinary Shares and Rights, Commencing February 25, 2025 - The Manila Times
Drugs Made In America Acquisition Corp. Announces The Separate Trading Of Its Ordinary Shares And Rights, Commencing February 25, 2025 - Marketscreener.com
SPAC Alert: Key Trading Change Coming for Drugs Made In America UnitsWhat Investors Should Track - StockTitan
Drugs Made In America Acquisition Corp. Announces Closing of Full Exercise of IPO Over-Allotment Option - The Manila Times
Drugs Made In America Acquisition Announces Closing Of Full Exercise Of IPO Over-Allotment Option - Marketscreener.com
ForexTV | Small Business Resources - ForexTV.com
Mink Ventures Completes Acquisition of Warren Ni, Cu, Co Patents - The Manila Times
Drugs Made In America Acquisition Corp. Secures Additional $30 Million in IPO as Underwriter Fully Exercises Overallotment Option - Nasdaq
Drugs Made In America Acquisition Corp. Announces Closing of Full Exercise of IPO ... - The Bakersfield Californian
Nortech Systems (NASDAQ:NSYS) Coverage Initiated by Analysts at StockNews.com - Defense World
Roy Twite Purchases 8 Shares of IMI plc (LON:IMI) Stock - Defense World
U.S. investors, Big Pharma race to find new medicines in China - CNBC
Drugs Made In America Acquisition Corp.’s $200 Million Initial Public Offering - Global Legal Chronicle
Pharma Co. Misled Investors On Depression Drug, Suit Says - Law360
JPMorgan BetaBuilders Developed Asia Pacific ex-Japan ETF (BATS:BBAX) Stock Price Up 3.3% – Time to Buy? - Defense World
Initial Public Offering (IPO) News Live Feed - StockTitan
Bain Capital to Acquire Mitsubishi Tanabe Pharma Corporation - Business Wire
Bain throws down $3.3B to acquire Japan's Mitsubishi Tanabe Pharma - FiercePharma
United Parcel Service (UPS) | History, Services, & Facts - Britannica
Mountain Commerce Bancorp (OTCMKTS:MCBI) Stock Passes Above 200-Day Moving Average – Here’s What Happened - Defense World
Our History - Baxter
Barclays Cuts Lennar (NYSE:LEN) Price Target to $121.00 - Defense World
IPO NewsUS IPO Weekly Recap: Active January closes out with several sizable IPOs - Renaissance Capital
Drugs Made In America Acquisition Corp. (NASDAQ: DMAAU) Successfully Completes $200 Million IPOFort Lauderdale, FL, Jan. 29, 2025 – Drugs Made In America Acquisition Corp. (NASDAQ: DMAAU) recently announced the successful closure of its initial - Defense World
Sellas Life Sciences Group Announces $25 Million Registered Direct Offering - Defense World
Allogene Therapeutics, Inc. Announces Departure of Timothy MooreOn January 23, 2025, Allogene Therapeutics, Inc. (NASDAQ: ALLO) revealed in an 8-K filing that Timothy Moore, the Company’s incumbent executive, would be concluding his tenure with the - Defense World
Drugs Made In America Acquisition Corp Stock (DMAAU) Financials Data
There is no financial data for Drugs Made In America Acquisition Corp (DMAAU). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.00%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):